Cases of Prostate Cancer Expected to Rise 24% in Europe by 2025, Along with Demand For Radiotherapy

Cases of Prostate Cancer Expected to Rise 24% in Europe by 2025, Along with Demand For Radiotherapy
Rising incidences of cancer across Europe, largely the result of people living longer, will increase demand for radiotherapy as a treatment option by an average of 16 percent by 2025 — with the highest increase likely to be in prostate cancer patients (24.4 percent), according to a  collaborative study involving researchers from Belgium, Denmark, Spain, France, and Australia. The study, "How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis," published in the Radiotherapy and Oncology journal, calls attention to the need to invest now in new radiotherapy equipment to meet the expected demand. Based on demographic changes, four million new cancer patients are expected by 2025 in Europe, and many would benefit from radiotherapy treatment. For this reason, researchers said it is important to prepare for the future demand. "Because radiotherapy involves significant outlay in equipment costs as well as in staff, long-term planning is necessary in order to achieve the required results. We, therefore, decided to try to forecast the radiotherapy needs of new cancer patients in the short to medium term in order to gain sufficient time for the purchase of appropriate machinery and the personnel training that will be required to meet this need," Professor Yolande Lievens, from the Radiation Oncology Department, Ghent University Hospital, Ghent, Belgium, said in a 
Subscribe or to access all post and page content.